Median Technologies: iBiopsy®, enhancing imaging diagnostic accuracyLearn more about Median and iBiopsy®, our unique end-to-end AI-powered Software as a Medical Device (SaMD) that supports radiologists and clinicians in the screening, early diagnosis and treatment in oncology and metabolic diseases.
Median Technologies: Imaging in Clinical Trials Solutions and ServicesLearn more about iSee and Median’s Imaging in Clinical Trials Solutions and Services
Imaging 101: RECIST 1 1 CriteriaWelcome to Median’s Imaging 101 series – short subject webinars on the fundamentals of imaging in clinical trials. In this session “Response Evaluation Criteria in Solid Tumors, RECIST 1.1 you will learn about the most commonly used response criteria in oncology clinical trials: RECIST 1.1.
Imaging 101: Medical Imaging Oncology ReviewWelcome to Median’s Imaging 101 series – short subject webinars on the fundamentals of imaging in clinical trials. In this session “Medical Imaging in Oncology Review” you will learn the fundamentals of medical imaging in oncology, basic terms, and advantages and disadvantages of various imaging modalities.
Median Technologies: Imaging in Clinical Trials
At Median we’re determined to push the boundaries of what Imaging Technology can achieve, to help develop next-generation treatments with the potential to save or improve the lives of millions. We’re already transforming the use of medical images in Clinical Trials and patient care; extracting the highest quality, most advanced Imaging Biomarkers to set the standard for developing new therapies, diagnosing disease and treating patients. We’re helping biopharmaceutical organizations around the world make quicker, better-informed decisions, bringing new therapies closer every day.